AdaptHealth Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 0/6

AdaptHealthDie Gewinne des Unternehmens sind mit einer durchschnittlichen jährlichen Rate von -44.5% zurückgegangen, während in der Branche Healthcare die Gewinne wachsen. Die Umsätze sind gewachsen mit einer durchschnittlichen Rate von 36.9% pro Jahr.

Wichtige Informationen

-44.5%

Wachstumsrate der Gewinne

-11.6%

EPS-Wachstumsrate

Healthcare Wachstum der Industrie	8.5%
Wachstumsrate der Einnahmen	36.9%
Eigenkapitalrendite	-47.1%
Netto-Marge	-21.4%
Letzte Ertragsaktualisierung	31 Mar 2024

Jüngste Aktualisierungen vergangener Leistungen

Recent updates

Market Might Still Lack Some Conviction On AdaptHealth Corp. (NASDAQ:AHCO) Even After 50% Share Price Boost

Mar 07

AdaptHealth's (NASDAQ:AHCO) Returns On Capital Not Reflecting Well On The Business

Feb 16

Many Still Looking Away From AdaptHealth Corp. (NASDAQ:AHCO)

Jan 18

AdaptHealth (NASDAQ:AHCO) Use Of Debt Could Be Considered Risky

Nov 15

Returns On Capital At AdaptHealth (NASDAQ:AHCO) Paint A Concerning Picture

Oct 18

Is It Too Late To Consider Buying AdaptHealth Corp. (NASDAQ:AHCO)?

Sep 27

Here's What's Concerning About AdaptHealth's (NASDAQ:AHCO) Returns On Capital

Jul 19

Here's Why AdaptHealth (NASDAQ:AHCO) Is Weighed Down By Its Debt Load

Jul 04

Is Now The Time To Look At Buying AdaptHealth Corp. (NASDAQ:AHCO)?

Jun 16

AdaptHealth's (NASDAQ:AHCO) Returns On Capital Not Reflecting Well On The Business

Apr 10

Here's Why AdaptHealth (NASDAQ:AHCO) Is Weighed Down By Its Debt Load

Mar 22

Why AdaptHealth Corp. (NASDAQ:AHCO) Could Be Worth Watching

Feb 23

Investors Interested In AdaptHealth Corp.'s (NASDAQ:AHCO) Earnings

Jan 24

AdaptHealth (NASDAQ:AHCO) Has A Somewhat Strained Balance Sheet

Dec 16

We Ran A Stock Scan For Earnings Growth And AdaptHealth (NASDAQ:AHCO) Passed With Ease

Nov 28

AdaptHealth named a Fresh Pick at Baird after investor day

Sep 19

AdaptHealth: Operating Performance Stretching Up, Valuation Less So

Aug 30

AdaptHealth Q2 2022 Earnings Preview

Aug 08

AdaptHealth gains ahead of addition to S&P SmallCap 600

Aug 02

Here's Why AdaptHealth (NASDAQ:AHCO) Has A Meaningful Debt Burden

Jun 27

AdaptHealth: Strongest Home DME Distributor, But Industry Outlook Weak

May 19

Aufschlüsselung der Einnahmen und Ausgaben

Wie AdaptHealth Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.

Gewinn- und Umsatzhistorie

NasdaqCM:AHCO Einnahmen, Ausgaben und Erträge (USD Millions)
Datum	Einnahmen	Umsatz	Allgemeine und Verwaltungskosten
31 Mar 24	3,248	-695	248
31 Dec 23	3,200	-679	241
30 Sep 23	3,122	-427	225
30 Jun 23	3,075	42	218
31 Mar 23	3,009	40	214
31 Dec 22	2,971	63	210
30 Sep 22	2,903	87	214
30 Jun 22	2,800	125	212
31 Mar 22	2,689	184	222
31 Dec 21	2,465	142	236
30 Sep 21	2,115	40	149
30 Jun 21	1,746	-64	125
31 Mar 21	1,361	-131	81
31 Dec 20	1,071	-162	68
30 Sep 20	858	-91	79
30 Jun 20	710	-44	67
31 Mar 20	602	-50	58
31 Dec 19	530	-21	39
30 Sep 19	489	-8	42
30 Jun 19	454	8	37
31 Mar 19	398	14	32
31 Dec 18	345	23	24
31 Dec 17	193	10	12
31 Dec 16	174	-4	11

Qualität der Erträge: AHCO ist derzeit unrentabel.

Wachsende Gewinnspanne: AHCO ist derzeit unrentabel.

Analyse von freiem Cashflow und Gewinn

Analyse des Gewinnwachstums in der Vergangenheit

Ergebnisentwicklung: AHCO ist unrentabel, und die Verluste haben in den letzten 5 Jahren mit einer Rate von 44.5% pro Jahr zugenommen.

Beschleunigtes Wachstum: Das Gewinnwachstum des letzten Jahres kann nicht mit dem 5-Jahres-Durchschnitt von AHCO verglichen werden, da das Unternehmen derzeit nicht profitabel ist.

Erträge im Vergleich zur Industrie: AHCO ist unrentabel, was einen Vergleich des Gewinnwachstums des letzten Jahres mit der Branche Healthcare (15.1%) erschwert.

Eigenkapitalrendite

Hohe Eigenkapitalrendite: AHCO hat eine negative Eigenkapitalrendite (-47.08%), da es derzeit unrentabel ist.

AdaptHealth Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 0/6

Wichtige Informationen

Jüngste Aktualisierungen vergangener Leistungen

AdaptHealth Corp. Announces Goodwill Impairment for the First Quarter Ended March 31, 2024

First quarter 2024 earnings released: US$0.016 loss per share (vs US$0.11 profit in 1Q 2023)

AdaptHealth Corp. to Report Q1, 2024 Results on May 07, 2024

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

AdaptHealth Corp. to Report Q4, 2023 Results on Feb 27, 2024

AdaptHealth Corp. to Report Q3, 2023 Results on Nov 07, 2023

Recent updates

Levi & Korsinsky LLP Encourages to File a Claim Against the Settlement Fund Before Deadline Against Adapthealth Corp

AdaptHealth Corp.'s (NASDAQ:AHCO) Low P/S No Reason For Excitement

Jerry W. Ray V. AdaptHealth Corp. Class Action Reaches Important Milestones

AdaptHealth (NASDAQ:AHCO) Is Reinvesting At Lower Rates Of Return

AdaptHealth Corp. Announces Goodwill Impairment for the First Quarter Ended March 31, 2024

First quarter 2024 earnings released: US$0.016 loss per share (vs US$0.11 profit in 1Q 2023)

AdaptHealth Corp. to Report Q1, 2024 Results on May 07, 2024

AdaptHealth Corp. Announces Richard Barasch Steps Down as Chairman of the Board, Effective June 30, 2024

AdaptHealth Corp., Annual General Meeting, Jun 20, 2024

Here's Why AdaptHealth (NASDAQ:AHCO) Has A Meaningful Debt Burden

Market Might Still Lack Some Conviction On AdaptHealth Corp. (NASDAQ:AHCO) Even After 50% Share Price Boost

Chief Technology Officer notifies of intention to sell stock

Insufficient new directors

AdaptHealth Corp. Provides Earnings Guidance for the Fiscal Year 2024

Price target increased by 13% to US$11.70

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

AdaptHealth's (NASDAQ:AHCO) Returns On Capital Not Reflecting Well On The Business

AdaptHealth Corp. to Report Q4, 2023 Results on Feb 27, 2024

Consensus EPS estimates fall by 34%

Many Still Looking Away From AdaptHealth Corp. (NASDAQ:AHCO)

Price target decreased by 8.7% to US$10.50

Rosen Law Firm Encourages AdaptHealth Corp. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action

AdaptHealth (NASDAQ:AHCO) Use Of Debt Could Be Considered Risky

New minor risk - Share price stability

Adapthealth Corp. Updates Revenue Guidance for the Year 2023

Bernstein Litowitz Berger & Grossmann LLP Announces the Filing of Securities Class Action Lawsuit Against AdaptHealth Corp

AdaptHealth Corp. to Report Q3, 2023 Results on Nov 07, 2023

Returns On Capital At AdaptHealth (NASDAQ:AHCO) Paint A Concerning Picture

Investor sentiment deteriorates as stock falls 16%

Is It Too Late To Consider Buying AdaptHealth Corp. (NASDAQ:AHCO)?

Adapthealth Corp. Announces CEO Changes

Investor sentiment deteriorates as stock falls 17%

Chief Technology Officer notifies of intention to sell stock

AdaptHealth Corp. Provides Revenue Guidance for the Fiscal Year 2023

Price target increased by 8.3% to US$17.03

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Here's What's Concerning About AdaptHealth's (NASDAQ:AHCO) Returns On Capital

Here's Why AdaptHealth (NASDAQ:AHCO) Is Weighed Down By Its Debt Load

Investor sentiment improves as stock rises 18%

Adapthealth Corp. Announces CEO Changes

Is Now The Time To Look At Buying AdaptHealth Corp. (NASDAQ:AHCO)?

Consensus EPS estimates increase by 13%, revenue downgraded

First quarter 2023 earnings: EPS exceeds analyst expectations

Price target decreased by 19% to US$17.83

AdaptHealth Corp. Announces Stephen Griggs Not to Seek Re-Election to the Board

AdaptHealth's (NASDAQ:AHCO) Returns On Capital Not Reflecting Well On The Business

Here's Why AdaptHealth (NASDAQ:AHCO) Is Weighed Down By Its Debt Load

Consensus EPS estimates fall by 35%

Investor sentiment deteriorates as stock falls 32%

Price target decreased by 17% to US$23.60

Full year 2022 earnings: EPS misses analyst expectations

Why AdaptHealth Corp. (NASDAQ:AHCO) Could Be Worth Watching

Insider recently sold US$941k worth of stock

Investors Interested In AdaptHealth Corp.'s (NASDAQ:AHCO) Earnings

Insider recently sold US$4.0m worth of stock

AdaptHealth Corp. to Report Q4, 2022 Results on Feb 28, 2023

AdaptHealth (NASDAQ:AHCO) Has A Somewhat Strained Balance Sheet

Insider notifies of intention to sell stock

We Ran A Stock Scan For Earnings Growth And AdaptHealth (NASDAQ:AHCO) Passed With Ease

Insider recently sold US$1.7m worth of stock

High number of new directors

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Adapthealth Corp. Updates Earnings Guidance for the Fiscal Year 2022

AdaptHealth Corp. to Report Q3, 2022 Results on Nov 08, 2022

Insider recently sold US$2.4m worth of stock

Insider recently sold US$18m worth of stock

AdaptHealth named a Fresh Pick at Baird after investor day

AdaptHealth: Operating Performance Stretching Up, Valuation Less So

General Counsel & Secretary notifies of intention to sell stock